Beacon Investment Advisory Services’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Other funds holding PDSB
Beacon Investment Advisory Services's PDSB Position: Q2 2026 in Review
Beacon Investment Advisory Services held its PDS Biotechnology (PDSB) position steady in Q2 2026 at 5 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #809.
Beacon Investment Advisory Services first reported a position in PDSB in Q1 2026 and has held it in 2 quarters since. 3 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.
- Beacon Investment Advisory Services held 5 shares of PDS Biotechnology worth $5 as of Q2 2026.
- Beacon Investment Advisory Services left its PDS Biotechnology share count unchanged in Q2 2026.
- PDS Biotechnology made up ﹤0.01% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #809 holding.
- Beacon Investment Advisory Services first reported a position in PDS Biotechnology in Q1 2026 and has held it in 2 quarters since.
- 3 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.
Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.